theheart.org: Arrhythmia/EP, Electrophysiology news and education

Arrhythmia/EP

Feb 16, 2010 13:42 EST

Join Drs. Halperin, Wallentin, and Oldgren as they discuss the results of the RE-LY post-hoc analysis, the RE-DEEM trial in ACS results, and the role of anticoagulants and antiplatelet therapy in clinical practice

Arrhythmia/EP

Atrial Fibrillation Stroke Prevention: A Latin American Perspective

Nov 25, 2009 17:05 EST

A high-risk patient for stroke, stent thrombosis, and bleeding presents a difficult but not unusual challenge. Drs. Lopes, Granger, and Alexander discuss how to balance the risks.

Arrhythmia/EP

Challenges in Warfarin Use and Future Directions of Stroke Prevention in Patients With Atrial Fibrillation: A Global Perspective

2 COMMENTS - Nov 25, 2009 11:27 EST

When is an effective, inexpensive, generic drug a liability? Such is the case for warfarin when reliable monitoring is either not available or untrustworthy. In many areas of the world, including rural areas of the United States and Latin America, eligible patients go untreated and are at risk for stroke. What does the future hold? Join Drs. Garcia, Carvalho, Granger, and Alexander for a discussion.

Arrhythmia/EP

Identifying Atrial Fibrillation - Preventing Stroke

2 COMMENTS - Nov 13, 2009 09:32 EST

Join Dr. Naccarelli as he leads a panel of experts consisting of Drs. Oseroff, Capucci and Lau, in a discussion.

Arrhythmia/EP

Preventing Stroke in Patients With Atrial Fibrillation: Late-Breaking Clinical Trial Data From ESC 2009

Oct 19, 2009 14:03 EDT

Read Dr. Jonathan Piccini's review of prevention of stroke in AF and how the newly released results of clinical trials of novel antithrombotic agents will reduce the risk for stroke. Then listen to our international panel of experts, Drs. Camm, Granger, Prystowsky, and Yusuf, as they give their take on new data released at ESC 2009.

Arrhythmia/EP

In Depth Review of Late-Breaking Clinical Trials in AF Stoke Prevention

Oct 5, 2009 11:55 EDT

Join our international panel of experts, Drs. Lip, Halperin, Weitz, Ezekowitz, Wallentin, and Connolly as they present late-breaking results of the RE-LY trial.

CME provider: MedscapeCME.
The AF Stroke Prevention clinical theme is supported by an independent educational grant from Boehringer Ingelheim.

	True
	False